A two-center prospective cohort study of serum RIP-3 as a potential biomarker in relation to severity and prognosis after severe traumatic brain injury

Neurosurg Rev. 2024 Aug 14;47(1):433. doi: 10.1007/s10143-024-02658-9.

Abstract

Receptor-interacting protein kinase-3 (RIP-3) is a key component for inducing necroptosis following acute brain injury. Purpose of this study is to unveil whether serum RIP-3 levels are related to severity and clinical outcomes after human severe traumatic brain injury (sTBI). In this two-center prospective cohort study, serum RIP-3 levels were detected in 127 healthy controls coupled with 127 sTBI patients. The prognostic indicators encompassed posttraumatic 180-day mortality, overall survival and poor prognosis (defined as extended Glasgow outcome scale scores of 1-4). The prognosis associations were verified via multivariate analysis. There was a significant incremental serum RIP-3 levels in patients with sTBI, relative to the controls. RIP-3 levels of patients were independently correlated with Rotterdam Computed Tomography (CT) scores and Glasgow coma scale (GCS) scores, as well as were independently predictive of mortality, overall survival and poor prognosis. Mortality and poor prognosis were effectively predicted by serum RIP-3 levels under the receiver operating characteristic curve. Linear relationships between RIP-3 levels and their risks were verified. Mortality and poor prognosis models of serum RIP-3 levels combined with GCS and Rotterdam CT scores displayed efficient predictive abilities. The two models were graphically represented, which were of clinical stability and value by employing the calibration and decision curves. Increased serum RIP-3 levels after sTBI are closely linked to heightened trauma severity and poor prognosis, signifying that serum RIP-3 may be an encouraging biomarker for evaluating severity and predicting clinical outcome of sTBI.

Keywords: Biomarkers; Outcome; Prognosis; Receptor-interacting protein kinase − 3; Severity; Traumatic brain injury.

Publication types

  • Multicenter Study

MeSH terms

  • Adult
  • Aged
  • Biomarkers* / blood
  • Brain Injuries, Traumatic* / blood
  • Brain Injuries, Traumatic* / diagnosis
  • Brain Injuries, Traumatic* / mortality
  • Cohort Studies
  • Female
  • Glasgow Coma Scale
  • Humans
  • Male
  • Middle Aged
  • Prognosis
  • Prospective Studies
  • Receptor-Interacting Protein Serine-Threonine Kinases* / blood
  • Young Adult

Substances

  • Biomarkers
  • Receptor-Interacting Protein Serine-Threonine Kinases
  • RIPK3 protein, human